Abstract:Background: Epigenetic mechanisms such as 5-methylcytosine (5mC) DNA methylation, histone acetylation and long non-coding RNAs (lncRNAs) are associated with aging processes and cardiovascular disease. Modification of the novel N6-methyladenine (m6A) DNA implicates this epigenetic mark in human malignant disease, but its role in atherosclerosis (AS) is largely unknown.Methods: We used ELISA to determine leukocyte global 5mC and m6A levels in 207 AS patients and 142 sex- and age-matched controls. Gene expression was examined by qRT-qPCR, western blot analysis and immunohistochemistry in mice with AS induced by a western diet, and oxidized low-density lipoprotein (ox-LDL)-treated human umbilical vein endothelial cells (HUVECs) and human monocytic cells (THP-1). Chromatin immunoprecipitation (ChIP) assay and dual-luciferase reporter assay were used to measure the transcriptional regulation of the lncRNA myocardial infarction-associated transcript (MIAT). Linear regression analysis was used to assess predictors of progression of carotid plaque size and carotid intima media thickness (CIMT).Findings: Leukocyte level of m6A but not 5mC was decreased with increased carotid plaque size and CIMT in AS patients. Serum LDL and leukocyte m6A levels were associated with progression of carotid plaque size and CIMT. LDL level and CIMT were also independently related to m6A level. Reduced m6A level was further confirmed in leukocytes and endothelium in WD-induced AS mice and ox-LDL treated HUVECs and THP-1 cells. Decreased m6A level was related to upregulated ALKBH1, the demethylase of m6A. Silencing of ALKBH1 or hypoxia-inducible factor 1α (HIF1α) could rescue the ox-LDL-increased level of MIAT, a hypoxia-response gene. Mechanically, ox-LDL induced HIF1α for transfer into the nucleus. Nuclear HIF1α bound to the ALKBH1-demethylated MIAT promoter and transcriptionally upregulated its expression.Interpretation: Elevated ALKBH1 level in endothelium and leukocytes reduced m6A level, which is associated with plaque progression. The lncRNA MIAT was identified as a novel target of m6A DNA methylation in AS pathogenesis.Funding: This work was supported by the National Natural Science Foundation of China (Grant numbers: 81970257 and 81778272) and the CAMS Innovation Fund for Medical Sciences (Grant numbers: 2017-I2M-3-005).Declaration of Interest: All other authors declared no conflict of interest.Ethical Approval: The protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University in October 2018 (no. L-2018-43). Signed informed consent was obtained from each participant before entering this study.

N6-Methyladenine DNA Associated with Plaque Progression in Atherosclerosis Via Myocardial Infarction-Associated Transcript

Sex-dichotomous Effects of NOS1AP Promoter DNA Methylation on Intracranial Aneurysm and Brain Arteriovenous Malformation.

Abstract 4827: N6-Methyladenosine Modification of LINC00901 Promotes Pancreatic Cancer Progression

Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice

M6A plays a potential role in carotid atherosclerosis by modulating immune cell modification and regulating aging-related genes

DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A2 in human vulnerable atherosclerotic plaque

Alteration of N6-methyladenosine Modi Fi Cation Pro Fi Les in the Neutrophilic RNAs Following Ischemic Stroke

Bioinformatic analysis and experimental validation identified DNA methylation–Related biomarkers and immune-cell infiltration of atherosclerosis

RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming

m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy

Characterization of the m6A regulators' landscape highlights the clinical significance of acute myocardial infarction

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases

Increased m6A methylation level is associated with the progression of human abdominal aortic aneurysm

Role of N6-methyladenosine modification in pathogenesis of ischemic stroke

Integrated analysis of differentially m6A modified and expressed lncRNAs for biomarker identification in coronary artery disease

Site‐specific m6A‐miR‐494‐3p, not unmethylated miR‐494‐3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis

Aberrant Hypermethylation of Aldehyde Dehydrogenase 2 Promoter Upstream Sequence in Rats with Experimental Myocardial Infarction

Identification of key genes with abnormal RNA methylation modification and selected m6A regulators in ankylosing spondylitis

DNA Methylation Aberrant in Atherosclerosis

Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis

KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner